Antisense therapy for the treatment of bacterial infections is a very attractive alternative to overcome drug resistance problems. However, the penetration of antisense oligonucleotides into bacterial cells is a major huddle that has delayed research and application in this field. In the first part of this study, we defined efficient conditions to encapsulate plasmid DNA and antisense oligonucleotides in a fluid negatively charged liposome. Subsequently, we evaluated the potential of liposome-encapsulated antisense oligonucleotides to penetrate the bacterial outer membrane and to inhibit gene expression in bacteria. It was found that 48.9 þ 12% and 43.5 þ 4% of the purified plasmid DNA and antisense oligonucleotides were respectively encapsulated in the liposomes. Using fluorescence-activated cell sorting analysis, it was shown, after subtraction of the fluorescence values due to the aggregation phenomenon measured at 4³C, that about 57% of bacterial cells had integrated the encapsulated antisense oligonucleotides whereas values for free antisenses were negligible. The uptake of the encapsulated anti-lacZ antisense oligonucleotides resulted in a 42% reduction of L-galactosidase compared to 9% and 6% for the encapsulated mismatch antisense oligonucleotides and the free antisense oligonucleotides respectively. This work shows that it is possible to encapsulate relatively large quantities of negatively charged molecules in negative fluid liposomes and suggests that fluid liposomes could be used to deliver nucleic acids in bacteria to inhibit essential bacterial genes. ß 2001 Elsevier Science B.V. All rights reserved.
Introduction
The increase of bacterial resistance to conventional antibiotics has become a major problem giving rise to an urgent need for new approaches to treat bacterial infections. In cystic ¢brosis patients, pathogens like Pseudomonas aeruginosa show high levels of resistance and lead to progressive lung deterioration and premature death [1^4] . To overcome antibiotic resistance, £uid liposomes named Fluidosomes, a negatively charged liposomal formulation without cholesterol and made of a combination of dipalmitoylphosphatidylcholine (DPPC) and dimyristoylphosphatidylglycerol (DMPG) phospholipids (at a molar ratio from 5:1 to 18:1) were developed. These liposomes with an overall low gel^liquid crystalline transition temperature (T C ) 937³C [5] were conceived as a delivery vehicle to enhance drug penetration through bacterial membranes [6, 7] . These £uid liposome-encapsulated antibiotics succeed in eradicating P. aeruginosa in an animal model of chronic pulmonary infection [6] . Recently, the superior e¤-ciency of £uid liposome-encapsulated aminoglycoside over rigid liposomes in an animal model of bacterial infection was supported by an independent group [8] .
The enhanced bactericidal activity of £uid liposomes would result from a mechanism of fusion between the liposomes and the bacterial membranes as demonstrated by our group [9] . Previous studies analyzing the innocuousness of £uid liposomes have demonstrated that they do not induce an immune response following repeated intraperitoneal and intratracheal administrations to mice [10] and cannot fuse with human lung epithelial cells [11] .
Antisenses can regulate gene expression by binding to a complementary mRNA strand by conventional Watson^Crick hydrogen bonds, thereby providing speci¢c targeting to the mRNA [12] . Because antisense oligonucleotides are highly susceptible to intracellular endonucleases, considerable e¡orts have been made to develop chemical modi¢cations to improve their stability. Phosphorothioate oligonucleotides are the most commonly used and widely commercially available chemically modi¢ed oligonucleotides, in which the non-bridging oxygen atoms are replaced by sulfur in the DNA backbone of the molecule. This modi¢cation increases resistance to nuclease degradation [13] . Selective inhibition of bacterial genes to kill bacteria or to alter their resistance o¡ers many advantages over conventional chemotherapies. Antisense oligonucleotides can be speci¢cally designed to target only bacterial sequences thus not a¡ecting eukaryotic cells. Also, there are no known mechanisms by which bacteria could expulse antisense oligonucleotides outside their cytoplasm like they do with common antibiotics using e¥ux pumps [14^16] . Moreover, a recent study demonstrated that the activities of drug e¥ux pumps do not a¡ect antisense nucleic acid susceptibility [17] .
In this study, we ¢rst tested di¡erent types of solutions (NaCl, KCl, NaHCO 3 , MgCl 2 , CaCl 2 and phosphate-bu¡ered saline (PBS)) for the encapsulation of plasmid DNA and antisense oligonucleotides in negatively charged Fluidosomes. The second part of this study consisted in the analysis of the uptake of the encapsulated antisense oligonucleotides by Escherichia coli CSH36 expressing a normal outer membrane which was evaluated by £uorescence-activated cell sorting (FACS). The functional transfer of DNA in an E. coli strain which constitutively expresses the lacZ (L-galactosidase) gene due to a mutation in the regulatory lacI gene, was assessed by the reduction of L-galactosidase activity after the incubation of E. coli CSH36 with the encapsulated phosphorothioate anti-lacZ antisense oligonucleotide.
Materials and methods

Bacterial strain and antisenses
The pUC 18 plasmid (New England BioLabs, Beverly, MA, USA) was used for the study of DNA encapsulation. E. coli CSH36 (alternate name E7074), a laboratory strain which constitutively expresses the lacZ gene due to a mutation in the regulatory lacI gene, was used [18] . Bacteria were grown in LB broth (Gibco BRL, Life Technologies, ON, Canada). An anti-L-galactosidase antisense oligonucleotide was designed to target the start codon region of the E. coli L-galactosidase gene: 5P-GGT CAT AGC TGT TTC-3P [19] . A mismatch antisense oligonucleotide was also designed and used as a negative control: 5P-TAC TGT GAT CTG TGC-3P. The antisense oligonucleotides used in the present study had a phosphorothioate backbone. This modi¢cation was obtained by a substitution of a non-bridging oxygen for a sulfur in the oligonucleotide backbone in order to render the antisenses more stable and less subject to degradation by endonucleases [19] . These phosphorothioate antisense oligonucleotides were ordered from Alpha DNA (Montreal, QC, Canada). After salt removal, the lyophilized oligonucleotides were rehydrated with PBS 1X. FITC-labeled antisense oligonucleotides used in uptake measurements were obtained from Synthegen (Houston, TX, USA). Unless otherwise indicated, encapsulated oligonucleotide antisenses were added at a concentration of 10 WM.
Fluid liposomes
Fluid liposomes were prepared from synthetic phospholipids DPPC and DMPG (Avanti Polar Lipids, Alabaster, AL, USA) at a molar ratio of 10:1. Liposomes were prepared by a dehydration^rehydra-tion vesicle (DRV) method as previously described [6, 9] . Brie£y, appropriate amounts of both phospholipids were dissolved in chloroform in a round-bottomed £ask and dried to a lipid ¢lm by rotoevaporation (Bu « chi Rotavapor) at 65³C under vacuum (Bu « chi 168-Vacuum/Distillation Controller). The lipids were then redissolved in PBS 1:20 and transferred to screw neck diagnostic bottles with thin £ange lyophilization stoppers designed for lyophilization and hypodermic applications (Wheaton, NJ, USA). The liposomes were then freeze-dried (Virtis Genesis 12 EL Console freeze dryer, Canberra Parkard, Toronto, ON, Canada) at 4³C. At the end of the lyophilization process, the bottles were mechanically closed under vacuum. Finally, the stoppers were sealed with aluminum caps and the bottles were kept at 370³C until use.
Encapsulation and quanti¢cation of the enclosed DNA
The pUC 18 plasmid was puri¢ed using the Concert Plasmid Maxiprep System (Life Technologies, Gibco BRL, USA) and quanti¢ed by OD 260 using an UV-visible spectrophotometer (Milton Roy Spectronic 1001 plus, USA). To encapsulate DNA, a volume of 0,5 ml of puri¢ed plasmid DNA (0.2 mg/ml of encapsulation solution) or of antisense oligonucleotides (7.4 mg/ml of PBS) was injected into the diagnostic bottles containing the lyophilized phospholipids (15 mg of phospholipids) which were kept under vacuum during the procedure. The hydrated phospholipids were vortexed until the powder was completely dissolved in the DNA solution. The bottles, still under vacuum, were incubated at 65³C with agitation (100 rpm) for 60 min. Vortexing was performed every 10 min. After the incubation period, the liposome^DNA solution was diluted in 9.5 ml of encapsulation solutions. These solutions contained either NaCl (50 mM and 150 mM), KCl (50 mM), NaHCO 3 (50 mM), CaCl 2 (50 mM), or MgCl 2 (50 mM) prepared in sterile distilled water and PBS (NaCl 137 mM, KCl 2.7 mM, Na 2 HPO 4 10 mM, K 2 HPO 4 1.8 mM). The diluted liposomes were centrifuged at 6000Ug for 40 min in order to remove the DNA present in the supernatant. Plasmid DNA (250 Wg) was resuspended in 1000 Wl of encapsulation solution. Each encapsulation solution was tested at least three times. The liposome diameters were heterogenous: about 63% of the size distribution measurements of liposomes was shifted towards the diameter range comprised between 316.2 and 562.3 nm whereas about 46% consisted in large heterogeneous vesicles as determined by an electronic particle size analyzer (Coulters Electronics, Miami, FL, USA).
The antisense oligonucleotides encapsulated in liposomes were quanti¢ed using Oligreen (Molecular Probes, Eugene, OR, USA) as described by the manufacturer, and a Perkin-Elmer LS-50B £uorescence spectrophotometer (excitation at 490 nm, emission at 520 nm). Before performing the cytometry studies, a sample of the FITC-labeled antisense oligonucleotides encapsulated in liposomes was submitted to DNA extraction for quanti¢cation using a methanol^chloroform (1:2) solution and a Perkin-Elmer LS-50B £uorescence spectrophotometer (excitation at 490 nm, emission at 520 nm).
Monitoring DNA localization
Two methods were used to con¢rm that DNA was present inside and not outside of the liposomes. The ¢rst method consisted in placing DNA-encapsulated liposomes and controls in an agarose gel (0.4%) containing ethidium bromide (0.5 Wg/ml). The gel was submitted to an electric current of 7 V/cm to obtain free DNA migration. The second method to ascertain that the measured DNA was contained inside the liposomes consisted in treating the preparation with DNase in order to eliminate the DNA present outside of the liposomes. The DNase treatment for 15 mg of phospholipids rehydrated with 250 Wg of DNA consisted in 250 DNase units, 5 mM MgCl 2 , 0.1 M sodium acetate and lasted for 3 h at room temperature. The reaction was stopped with 20 mM EDTA. After the DNase treatment, liposomes were dissolved and separated from DNA as described below. The DNA was quanti¢ed and compared to untreated liposome-encapsulated DNA. The control for DNase activity consisted in adding an equivalent amount of DNA to empty liposomes (externally), followed by treatment with DNase and quanti¢ca-tion of the resulting DNA. All DNA quanti¢cations in gels were determined visually.
UV absorbance measurements of DNA
To evaluate the e¤ciency of DNA encapsulation with the di¡erent encapsulation solutions, UV absorbance measurements were performed after liposomes were dissolved in a methanol^chloroform (1:2) solution. The lipids were present in the organic phase whereas DNA was found in the aqueous phase. The aqueous phase containing plasmid DNA and antisense oligonucleotides was diluted 1/100 in the di¡erent encapsulation solutions and analyzed on an Milton Roy Spectronic 1001 plus spectrophotometer. Samples were placed in quartz cuvettes and scanned at A 260 . Standard curves were drawn in the di¡erent encapsulation solutions with concentrations of DNA varying from 0.001 mg/ml to 0.5 mg/ml.
Delivery of the encapsulated antisense oligonucleotides in E. coli
Bacteria were grown overnight in LB broth (Gibco BRL, Life Technologies, ON, Canada). From this culture, 300 Wl were added to 10 ml of fresh LB broth. The culture was grown to mid-logarithmic phase then diluted to an optical density (OD) of 0.05 at 600 nm. Six tubes containing the same volume of this bacterial culture were prepared and different concentrations of free FITC-labeled antisense oligonucleotides, encapsulated FITC-labeled antisense oligonucleotides and PBS-containing liposomes were added. Bacteria were incubated for 4 h at 37³C with vigorous shaking. Samples from each tube were placed on the surface of a 24% sucrose (Sigma, ON, Canada) cushion and centrifuged at 4³C for 20 min (6000 rpm) in an Eppendorf Centrifuge 5402. Bacteria were washed once with LB broth, then placed on another sucrose cushion and centrifuged. The supernatant was discarded and the ¢nal cell pellet was ¢xed with 2% paraformaldehyde (Sigma) diluted in PBS. The solutions were kept at 4³C overnight. Bacteria were analyzed by means of a FACS Calibur £ow cytometer (Becton Dickinson). Forward angle (FSC) and 90³ light (side) scattering (SSC) measurements as well as green (FL1) £uorescence were collected, and 10 000 events were counted for each sample. The purity of the bacterial population sorted after electronic gating was closed to 100%.
Determination of L-galactosidase activity
Bacteria were prepared as described above. Free antisense oligonucleotides, encapsulated antisense oligonucleotides, encapsulated mismatch antisense oligonucleotides, free mismatch oligonucleotides and encapsulated PBS were added to bacteria and incubated for 4 h at 37³C with agitation. In this assay, a single data point of 4 h was selected based on the results obtained following the time course of the FACS analysis. Samples from each tube were placed on the surface of a 24% sucrose cushion and centrifuged for 20 min at 6000 rpm, 4³C. Supernatants were discarded and bacteria were resuspended in Z bu¡er (8.52 g Na 2 HPO 4 , 5.5 g NaH 2 PO 4 WH2O, 0.75 g KCl, 0.246 g MgSO 4 W7H 2 O, 2.7 ml L-mercaptoethanol per liter; pH 7). L-Galactosidase concentration was measured using the substrate o-nitrophenyl-L-galactoside (Sigma) as previously described [18] with minor modi¢cations: after the incubation period with the substrate, the bacteria were treated with 20 Wl of chloroform (EM Science, Gibbstown, NJ, USA) and 20 Wl of 0.1% SDS (Bio-Rad, Hercules, CA, USA). The solution was vortexed for 10 s and placed at 30³C for 5 min. The absorbance was measured at 420 nm using a spectrophotometer (Milton Roy Spectronic 1001 Plus).
Results
DNA encapsulation with the di¡erent encapsulation solutions
The two encapsulation solutions containing CaCl 2 (50 mM, pH 7.0) or MgCl 2 (50 mM, pH 7.0) caused the DNA and liposomes to precipitate thus allowing visualization by ethidium bromide staining in the agarose gel where the DNA was visible in the wells at the end of the migration period (Fig. 1b, lanes 1,  4, 7, 10 ). Also, a precipitate was visible when the solution was observed in the tube. The encapsulation solutions composed of salts containing monovalent cations, either NaCl (50 mM, and 150 mM, pH 7.0), KCl (50 mM, pH 7.0) or NaHCO 3 (50 mM, pH 7.0) and PBS were e¤cient in promoting the encapsulation of DNA in liposomes. At ¢rst, when these liposomes were placed in agarose gels, encapsulated DNA could not migrate, nor could it be detected in the wells (Fig. 1b, lanes 2, 3, 5, 6, 8, 9 ). However, following the lysis of these liposomes, migrating DNA could be observed (Fig. 1a, lanes 10,  11, 13, 16, 17, 19 ). The quantities of DNA detected in the gels after DNase treatment (lanes 10, 11, 13) were approximately the same and corresponded to about 50% of the DNA signal given by the initial DNA preparation dissolved in the encapsulation solution before encapsulation (Fig. 1a, lanes 2, 3, 5) . Negligible di¡erences in DNA quantities were observed between untreated (lanes 16, 17, 19) and DNase-treated liposome-encapsulated DNA (lanes 10, 11, 13).
The UV absorbance measurements of extracted DNA from eight independent preparations of liposome-encapsulated plasmid DNA and three independent preparations of encapsulated antisense oligonucleotides in PBS gave a mean encapsulation of 48.87 þ 11.65% and 43.53 þ 4.32% respectively.
Delivery of the encapsulated antisense oligonucleotides in bacteria
FACS analysis was performed at 37³C to determine if encapsulated antisense oligonucleotides could e¤ciently be delivered to bacteria. To assure that liposomes do not sediment at all during centrifugation through the sucrose cushion, a preliminary test was performed that consisted in adding only liposomes on the surface of the sucrose cushion. The cytometry analysis of the lower part (no pellet was visible) of the gradient showed a total absence of liposomes in this fraction. Other controls indicated that bacteria did not emit intrinsic £uorescence ( Fig.  2A) and no £uorescence was detected with £uid liposomes containing PBS used as negative control (data not shown). Bacteria treated with free antisense oligonucleotides showed very low levels of £uorescence (9.78%) (Fig. 2B) . After a 4 h incubation period of the bacteria with encapsulated FITC-antisense oligonucleotides, 71.25% of bacteria showed FITC-£uo-rescence (Fig. 2C) . To evaluate the extent of the aggregation phenomenon of liposomes and antisenses on the outer bacterial membrane versus the penetration of antisense in bacteria by liposome fusion, a kinetic study was performed at 4³C and 37³C. The results indicate that at time zero, £uorescence values were the same at 4³C and 37³C; after 4 h of incubation at 37³C, the bacterial £uorescence due to the liposome-encapsulated oligonucleotide transfer strongly increased with time (Fig. 3) . After subtraction of values obtained at time zero, the £uorescence that may be caused by agglutination (observed at 4³C) counted for 17% and 20% after 120 and 240 min respectively for the encapsulated antisenses compared to 43% and 100% after 120 and 240 min respectively for the free antisenses (Fig. 3) . This means that at the end of the experiment, aggregation only was observed between the free antisenses and the bacterial cells. On the other hand, 80% of the £uo-rescence observed with the encapsulated antisenses corresponded to a true antisense internalization which corresponded to 57%.
Determination of the L-galactosidase activity
The mismatch antisense oligonucleotide used as negative control contained the same amount of T, A, G and C deoxyribonucleotides as the anti-lacZ antisense oligonucleotide but in a di¡erent order. The addition of 25 WM of the encapsulated antilacZ antisense oligonucleotide to E. coli, with an incubation period of 4 h at 37³C, caused a signi¢cant reduction of L-galactosidase of 42% compared to 9% and 6% for the encapsulated mismatch antisense oligonucleotide and the free antisense oligonucleotide respectively (Fig. 4) . This result demonstrates that the encapsulated antisenses not only enter the bacterial cells, but interact with the target mRNA. In the second L-galactosidase assay, a dose-dependent activity using 5, 10, and 25 WM encapsulated antisense oligonucleotides causes the inhibition of the L-galactosidase whereas a plateau was reached with 50 WM. Gradual inhibitions of L-galactosidase activity of 4%, 26% and 42% were observed with the encapsulated antisense at 5, 10 and 25 WM respectively compared to w2^6% with free antisense and 0^9% with the encapsulated mismatch antisense (Fig. 5) . The inhibition of the L-galactosidase gene expression was dose-dependent ( Fig. 5) and was inhibited in a signi¢cant manner only with the encapsulated anti-lacZ antisense oligonucleotide (Fig. 5) . Free mismatch antisense oligonucleotide showed no gene inhibition (data not shown). Finally, our results show that the phosphorothioate antisense oligonucleotides were not degraded during the 4 h period at 37³C since their activity was maintained over that period of time.
Discussion
Multiple modes of DNA delivery have been developed for gene therapy [20] . Among the problems associated with DNA transfer in cells are the stability of the carrier DNA complex, toxicity and the e¤-cient delivery to and expression of the desired DNA in the cytoplasm. The use of viral particles, a very e¤cient method for gene delivery, involves potential risks of infection, immune reaction and may both slow the cell cycle and induce apoptosis [21, 22] . Although cationic liposome^DNA complexes present advantages over viral vectors, they have also major limitations due to aggregation behavior [23^25], signi¢cant toxicity [26^29] and low transgene expression Fig. 3 . Kinetics of antisense uptake in bacteria measured by FACS analysis as described in the text. E, control bacteria; l, free antisense oligonucleotides; F, encapsulated antisense oligonucleotides. (A) Experiment conducted at 37³C; (B) experiment conducted at 4³C. [30, 31] . Moreover, the problem of toxicity is a complex one since it would be independent of the cationic lipid:DNA ratio, the cationic lipid species and the level of transgene expression attained [27] . It has been suggested that the mechanism of toxicity of cationic lipids would depend on the alterations of the net charge of cell membranes and adverse e¡ects on the activity of ion channels, membrane receptors, and enzymes [32] . Another problem met with cationic liposome-mediated transfection is the low release of plasmid DNA from the liposome^DNA complex for e¤cient gene expression [33, 34] .
In the present work, entrapment of DNA in anionic DPPC/DMPG liposomes prepared with the DRV method using encapsulation solutions made of monovalent salts was signi¢cant both with plasmid DNA (48.3%) and antisense oligonucleotides (43.5%). Similar plasmid DNA entrapment values were reported with anionic PC:CHOL:PG liposomes [35] . It also appears that in solutions made with monovalent salts, the DNA quanti¢ed was practically only within the liposome considering that: (i) following its encapsulation, the DNA was protected from DNase degradation as demonstrated by the fact that approximately the same amount of DNA was detected in untreated and treated liposome-encapsulated DNA; (ii) free DNA could not be observed in agarose gel following the DNase treatment; (iii) encapsulated DNA could not be observed with ethidium bromide in agarose gel; (iv) DNA could be observed in agarose gel after lysis of the DNAencapsulated liposomes. It seems that, in contrast to DNA^liposome complexes where DNA is external, internalization of DNA would be favored in the multilamellar liposomes generated by the DRV process [35] . Moreover, in our hands, the addition of DNA preparation to the lyophilized liposomes under vacuum conditions during the whole process of rehydration contributes to the e¤ciency of the encapsulation procedure.
Liposomes are versatile drug carriers which can be associated with both hydrophilic and hydrophobic molecules. The ¢nding that a plasmid DNA^cationic liposome complex microinjected directly into the nucleus showed low transfection e¤ciency supports the hypothesis that the release of plasmid DNA from the complex is necessary for e¤cient gene expression in liposome-mediated transfection [34] . Xu and coworkers demonstrated that the anionic liposomes with a composition that mimics the cytoplasmic-facing monolayer of the plasma membrane rapidly released plasmid DNA from the complex [36] . In the absence of calcium ions, DNA molecules have no e¡ect on negatively charged liposomes because electrostatic repulsion prevents its interaction with anionic multilamellar vesicles [37] . Consequently, the use of anionic liposomes could help the release into cytoplasm of plasmid DNA from the liposome^D NA complex, a required step to the subsequent gene expression e¤ciency.
FACS analysis clearly shows that bacterial uptake of encapsulated antisense oligonucleotides is higher than the uptake of free antisense oligonucleotides. The di¡erence in number of £uorescent bacteria between the two preparations is very signi¢cant since it reached 71.25% with the encapsulated antisense oligonucleotides compared to 9.78% for the free ones (Fig. 2) . By running the same experiment at 4³C and 37³C (Fig. 3) , the values of £uorescence corresponding to aggregation (values obtained at 4³C) could be excluded. The results indicate that after an incubation period of 4 h at 37³C with the encapsulated antisense, the true value of the £uorescent antisense in the bacterial cells was 57% instead of 71%. Moreover, the same operation performed on the £uores-cence values due to free antisense indicates that the aggregation phenomenon represents the whole value of the observed £uorescence at the end of the experiment.
To demonstrate the activity of the anti-lacZ antisense oligonucleotides after their internalization in the bacterial cells, the inhibition of L-galactosidase production by E. coli CSH36, a bacterial strain that constitutively produces L-galactosidase, was measured. This strain was selected to avoid the addition of isopropyl L-D-thiogalactoside (IPTG) to the preparation since the latter could have been trapped in the £uid liposomes. In this case, IPTG would have been inaccessible to the surrounding bacteria and could have interfered with the normal induction of the targeted gene. To avoid the degradation of the antisense oligonucleotides by endonucleases, the antisenses used in the present study had a phosphorothioate backbone obtained by a substitution of a non-bridging oxygen by a sulfur in the nucleotide backbone. The stability of the antisenses used is well demonstrated by the results obtained after an incubation period of 4 h (Fig. 3) . A control using a non-modi¢ed antisense showed no gene inhibition (data not shown). The L-galactosidase inhibition obtained with the encapsulated anti-lacZ antisense oligonucleotides was concentration-dependent and reached a maximum level of 45% (Figs. 4 and 5 ). This limit is close to the percentage of bacterial cells (57%) which apparently show a true internalization of the antisense oligonucleotides from the liposomes.
The limit can also be related to the non-toxic e¡ect of the antisense for the bacteria. Thus, after the addition of the liposome-encapsulated anti-lacZ antisense oligonucleotides that combined with the bacteria, the sustained growing of new bacterial cells would continue to produce L-galactosidase during the 4 h incubation period. At concentrations of 25 and 50 WM, the encapsulated mismatch antisense oligonucleotides showed an inhibition of about 8%. This low level of inhibition could be attributed to a non-speci¢c steric hindrance after the penetration of the mismatch antisense into the bacterial cells. Some may argue that the diameter range of the majority of the liposomes that shifts towards 316^562 nm seems too large to allow fusion with bacteria of 1^5 Wm dimension. The fusion mechanism of the £uid liposomes with bacteria does not necessarily implicate the penetration of the whole liposome into the bacteria. It is possible that a partial fusion between bacterial and liposomal membranes occurs, allowing the penetration into the bacterial cytoplasm of liposomecontaining molecules. The well known conjugation process that exports e¡ector molecules into other cells demonstrates that such a transfer is possible. This hypothesis is not inconsistent with our previous work on the mechanism of fusion [9] and with the present results.
In conclusion, we showed that £uid anionic DRV liposomes can encapsulate, under vacuum condition, signi¢cant amounts of plasmid and oligonucleotide DNA using monovalent salt solutions. It is also demonstrated that DNA is entrapped within the multilamellar vesicles rather than being adsorbed to their surface. Because the toxicity problem of cationic liposomes may limit their clinical use, di¡erent types of anionic liposomes could be used to introduce genes both in bacterial and mammalian cells and enhance their expression. This study also suggests that anionic £uid liposomes directed at an essential gene start codon could be e¤ciently delivered inside bacteria and inhibit the gene's expression to eventually eliminate bacterial strains resistant to conventional antibiotics.
